
<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
    <title>About Us - OryGyn Medical Devices</title>
    <link rel="icon" href="assets/favicon.ico" type="image/x-icon">
    <style>
        body { font-family: Arial, sans-serif; margin: 0; padding: 0; background-color: #f1f8f6; }
        header, footer { background-color: #004d40; color: white; padding: 1em; text-align: center; }
        nav { background-color: #00796b; padding: 10px; text-align: center; }
        nav a { color: white; margin: 0 15px; text-decoration: none; font-weight: bold; }
        section { padding: 2em; max-width: 1000px; margin: auto; background: white; }
        h2 { color: #004d40; }
        .person { margin-bottom: 1.5em; }
        ul { padding-left: 1.5em; }
    </style>
</head>
<body>
    <header>
        <h1>About Us</h1>
    </header>
    <nav>
        <a href="index.html">Home</a>
        <a href="about.html">About Us</a>
        <a href="technology.html">Our Technology</a>
        <a href="pipeline.html">Pipeline</a>
        <a href="investors.html">Investors</a>
        <a href="contact.html">Contact</a>
    </nav>
    <section>
        <h2>Leadership Team</h2>
        <div class="person"><strong>Dr. Jeffrey T. Jensen, MD, MPH – Founder and Chief Medical Officer</strong><br>
        Renowned gynecologist and researcher with 35+ years in women’s health, previously at OHSU and currently leading development of gynecologic therapeutics.</div>

        <div class="person"><strong>Holly Rockweiler, MS – Chief Technology Officer</strong><br>
        CEO of Madorra and former Stanford Biodesign Fellow, experienced in medical device innovation and NIH-funded research.</div>

        <div class="person"><strong>Jian Xin Guo, PhD – Chief Scientific Officer</strong><br>
        Polymer chemist with a background at Johnson & Johnson and OHSU, specializing in foam-based therapeutic delivery systems.</div>

        <div class="person"><strong>Philberta Leung, PhD, PMP – Project Manager</strong><br>
        Neuroscientist and certified project manager with biotech experience, expert in database, IP, and team coordination.</div>

        <h2>Scientific Advisory Board</h2>
        <ul>
            <li><strong>Dr. David Archer</strong> – Clinical Trial Consultant: International expert in infertility, former president of multiple OB-GYN societies, active advisor since 2014.</li>
            <li><strong>Dr. Charles Carignan</strong> – Product Development Consultant: Ex-CEO of multiple medtech companies, former CMO of Boston Scientific, extensive FDA and WHO experience.</li>
            <li><strong>Bob Katz, MS, MBA</strong> – Product Development Consultant: CEO of ForwardVue Pharm, took VeraCept IUD from pre-clinical to Phase 3, business advisor for TSDS.</li>
            <li><strong>Dr. Amy Thurmond</strong> – Clinical Consultant: Pioneer in HSG-based infertility treatment, radiologist with 35 years’ experience and TSDS trial collaborator.</li>
            <li><strong>Dr. Lisa Rarick</strong> – Regulatory Consultant: Former FDA division director, now independent consultant, on OPERM advisory board since 2018.</li>
            <li><strong>Dr. Don Waller</strong> – Toxicology Consultant: UIC Professor Emeritus, product developer of Phexi, expert in pharmacology and toxicology for women’s health.</li>
        </ul>

        <h2>Business Advisory Board</h2>
        <ul>
            <li><strong>Sabrina Johnson</strong> – CEO of Daré Bioscience: Serial entrepreneur focused on women’s healthcare, former CFO/COO of Woman Care Global Trading, potential TSDS acquirer.</li>
            <li><strong>Dr. Brian A. Bernick</strong> – Chairman, Micron Biomedical: Co-founder of TherapeuticsMD, expert in clinical and commercial success of Annovera®, Bijuva®, and other women’s health products.</li>
            <li><strong>Andrew Barofsky, JD, MBA</strong> – CEO, RevMedx: Oregon biotech innovator behind trauma care devices and ObstetRX; former OBI board chair.</li>
            <li><strong>James Sailer</strong> – Co-President, Population Council: Led FDA approval and US launch of Annovera®. Heads global partnerships for contraceptive development and equitable access.</li>
        </ul>
    </section>
    <footer>
        <p>&copy; 2025 OryGyn Medical Devices, LLC. All rights reserved.</p>
    </footer>
</body>
</html>
